FDA Outlines Priorities For Next Five Years In Strategic Report

The agency identifies four overarching priorities: advancing regulatory science and innovation; strengthening the global supply chain; strengthening compliance and enforcement activities; and addressing unmet public health needs.

More from Archive

More from Pink Sheet